REG - Vistry Group PLC - Director/PDMR Shareholding

VistryAnnouncement

Wed 13:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251203:nRSC0615Ka&default-theme=true

RNS Number : 0615K  Vistry Group PLC  03 December 2025

Vistry Group PLC (the "Company")

 

PDMR/Shareholding Announcement

 

This announcement confirms that Browning West LP, a person closely associated
("PCA") with Usman Nabi, Non‑Executive Director of the Company, has
transferred 2,482,430 ordinary shares of 50p each in the Company ("Shares") as
part of a share distribution to an underlying investor. Browning West LP is an
independent investment partnership based in Los Angeles, California, and is
currently the Company's second largest shareholder. Usman Nabi serves as its
Managing Partner and Chief Investment Officer. Following the transfer,
Browning West remains the Company's second largest shareholder owning
28,269,558 Shares which equates to 8.81% of the Company's total voting rights.

The Company makes the below announcement and notification in accordance with
the requirements of the EU Market Abuse Regulation:

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Browning West LP

 2    Reason for the notification

 a)   Position/status                                              Person closely associated with Usman Nabi, Non-Executive Director

 b)   Initial notification /Amendment                              Initial notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         Vistry Group PLC

 b)   LEI                                                          2138001KOWN7CG9SLK53

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary Shares of 50p each

      Identification code

                                                                   GB0001859296

 b)   Nature of the transaction                                    Transfer of shares

 c)   Price(s) and volume(s)

Price(s)  Volume(s)

                                                                   £Nil      2,482,430

 

 d)   Aggregated information

      - Aggregated volume                                          2,482,430

      - Price                                                      £Nil

 e)   Date of the transaction                                      01/12/2025

 f)   Place of the transaction                                     London Stock Exchange (XLON)

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

2,482,430

 

 

£Nil

 

 

e)

 

Date of the transaction

 

 

01/12/2025

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHPKNBPFBDKCBK



            Copyright 2019 Regulatory News Service, all rights reserved